Home/Filings/4/0001225208-24-002580
4//SEC Filing

Thepaut Eric Francis Yves 4

Accession 0001225208-24-002580

CIK 0000885725other

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 9:05 PM ET

Size

13.3 KB

Accession

0001225208-24-002580

Insider Transaction Report

Form 4
Period: 2024-02-16
Thepaut Eric Francis Yves
SVP & Pres, Europe
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-16+2,26329,460.99 total
  • Tax Payment

    Common Stock

    2024-02-16$65.82/sh1,311$86,29028,149.99 total
  • Exercise/Conversion

    Common Stock

    2024-02-17+2,50030,649.99 total
  • Tax Payment

    Common Stock

    2024-02-17$65.82/sh1,448$95,30729,201.99 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-02-162,2634,526 total
    Exp: 2026-02-16Common Stock (2,263 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-02-172,5002,500 total
    Exp: 2025-02-17Common Stock (2,500 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  • [F2]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
  • [F3]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.

Documents

1 file

Issuer

BOSTON SCIENTIFIC CORP

CIK 0000885725

Entity typeother

Related Parties

1
  • filerCIK 0001631992

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 9:05 PM ET
Size
13.3 KB